Literature DB >> 30279883

A case of conservative management for left ventricular giant pseudoaneurysm without ST segment changes.

Daiki Ousaka1,2, Naruki Obara2, Megumi Fujiwara3, Koushi Nakagawa4, Akira Teraoka5, Shingo Kasahara1, Susumu Oozawa1,6.   

Abstract

Left ventricular (LV) rupture after myocardial infarction (MI) occasionally results in formation of LV pseudoaneurysm (LVPA) which is prone to rupture because of its thin wall. However, cases of LVPA without ST changes including segment elevation in electrocardiogram (ECG) are rare. In this case, we describe a patient who had relatively mild symptoms and giant LVPA with no specific ECG changes following MI with a confirmed diagnosis via transthoracic echocardiography. Although surgical treatment options are often recommended, conservative therapy was adopted, following which the patient had been well-medicated using antihypertensive drugs and anticoagulants. <Leaning objectives: Left ventricular pseudoaneurysm (LVPA) is usually accompanied by ST segment changes on electrocardiogram (ECG) due to myocardial damage. However, we should take into account a LVPA without ECG specific changes, so echocardiography is better to be considered for an identification. Although many LVPA patients undergo surgery because of risk for rupture, some cases with stable hemodynamic status can have long-term survival with conservative therapy such as anti-hypertension and coagulation.>.

Entities:  

Keywords:  Anticoagulation; Left ventricular pseudoaneurysm; Myocardial infarction; ST segment changes; Transthoracic echocardiography

Year:  2018        PMID: 30279883      PMCID: PMC6149656          DOI: 10.1016/j.jccase.2018.01.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  True and false left ventricular aneurysms. Propensity for the altter to rupture.

Authors:  Z Vlodaver; J I Coe; J E Edwards
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

Review 2.  Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management.

Authors:  Anurag Bajaj; Ankur Sethi; Parul Rathor; Nissi Suppogu; Arjinder Sethi
Journal:  J Investig Med       Date:  2015-10       Impact factor: 2.895

3.  Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition.

Authors:  R Gorlin; M D Klein; J M Sullivan
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

4.  Clinical profile and outcome in 52 patients with cardiac pseudoaneurysm.

Authors:  T C Yeo; J F Malouf; J K Oh; J B Seward
Journal:  Ann Intern Med       Date:  1998-02-15       Impact factor: 25.391

5.  Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria.

Authors:  J López-Sendón; A González; E López de Sá; I Coma-Canella; I Roldán; F Domínguez; I Maqueda; L Martín Jadraque
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

6.  Long term outcome of patients with postinfarction left ventricular pseudoaneurysm.

Authors:  R Moreno; E Gordillo; J Zamorano; C Almeria; J C Garcia-Rubira; A Fernandez-Ortiz; C Macaya
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

7.  Natural history of saccular aneurysms of the left ventricle.

Authors:  P Grondin; J G Kretz; O Bical; P Donzeau-Gouge; R Petitclerc; L Campeau
Journal:  J Thorac Cardiovasc Surg       Date:  1979-01       Impact factor: 5.209

Review 8.  Technical advances in the treatment of left ventricular aneurysm.

Authors:  N L Mills; C T Everson; D R Hockmuth
Journal:  Ann Thorac Surg       Date:  1993-03       Impact factor: 4.330

9.  Quantitative analysis of regional systolic function with left ventricular aneurysm.

Authors:  A C Nicolosi; H M Spotnitz
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

Review 10.  Left ventricular pseudoaneurysm.

Authors:  C Frances; A Romero; D Grady
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.